OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

PROGRESSIVE CORP. DL 1/  US7433151039  /

Hannover
02/09/2024  17:25:18 Chg. +2.55 Volume Bid21:22:43 Ask21:22:43 Market Capitalization Dividend Y. P/E Ratio
227.75EUR +1.13% 0
Turnover: 0.00		 -Bid Size: - -Ask Size: - 133.4 bill.EUR - -
GlobeNewswire 19/08 Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa
GlobeNewswire 19/08 Tiziana Life Sciences Appoints New Chief Executive Officer
GlobeNewswire 19/08 Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief ...
GlobeNewswire 19/08 CN Issues Lockout Notice to Teamsters
GlobeNewswire 15/08 Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire 14/08 Progressive Reports July 2024 Results
GlobeNewswire 14/08 Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene ...
GlobeNewswire 14/08 Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
GlobeNewswire 13/08 Eyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire 12/08 Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Newsfile Corp 12/08 The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
TeleTrader 11/08 Bank of Russia says rates could reach 20%
GlobeNewswire 08/08 Opthea to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15,...
GlobeNewswire 08/08 Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th
GlobeNewswire 07/08 Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Sus...
GlobeNewswire 07/08 AGS Unveils its Latest Table Innovation Bonus Spin Xtreme for Poker Rooms and an Exciting New Lineup...
GlobeNewswire 07/08 Team, Inc. Announces Timing of Second Quarter Earnings Release and Conference Call
TeleTrader 07/08 Cori Bush loses Missouri Democratic primary
GlobeNewswire 06/08 TG Therapeutics Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy)...
GlobeNewswire 06/08 Levicept Announces Positive Results of Phase II Trial of novel Neurotrophin-3 Inhibitor, LEVI-04, fo...
TeleTrader 06/08 Aramco's Q2 net income down 3.2% to $29.1 billion
GlobeNewswire 05/08 Progressive Announces Quarterly Common Share Dividend
GlobeNewswire 05/08 NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted...
GlobeNewswire 05/08 Annexon Provides Update on ARCHER II Global Registrational Program in Geographic Atrophy
GlobeNewswire 30/07 Progressive Announces Investor Relations Event